NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020
Fox Chase Cancer Center · The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute · +36 more institutions
Abstract
The NCCN Guidelines for Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic provide recommendations for genetic testing and counseling for hereditary cancer syndromes, and risk management recommendations for patients who are diagnosed with syndromes associated with an increased risk of these cancers. The NCCN panel meets at least annually to review comments, examine relevant new data, and reevaluate and update recommendations. These NCCN Guidelines Insights summarize the panel's discussion and most recent recommendations regarding criteria for high-penetrance genes associated with breast and ovarian cancer beyond BRCA1/2, pancreas screening and genes associated with pancreatic cancer,…
Citation impact
- FWCI
- 69.24
- Percentile
- 100%
- References
- 98
Authors
33- MBMary B. DalyCorresponding
Fox Chase Cancer Center
- RPRobert Pilarski
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
- MBMatthew B. Yurgelun
Dana-Farber Brigham Cancer Center
- MPMichael P. Berry
St. Jude Children's Research Hospital, University of Tennessee Health Science Center
- SSSaundra S. Buys
University of Utah, Huntsman Cancer Institute
Topics & keywords
- Medicine
- Genetic testing
- Penetrance
- Genetic counseling
- Ovarian cancer
- Pancreatic cancer
- Gynecology
- Oncology
- Peace, Justice and strong institutions